Heart Failure Archives - Cardio ThinkLab

Heart Failure

Reducing Mortality and Readmission with HF Multidisciplinary Model of Care featured image

Reducing Mortality and Readmission with HF Multidisciplinary Model of Care

Dr Gary Gan

Screening for Occult Heart Failure (HF) in Type 2 Diabetes Mellitus (T2DM) using NT-proBNP featured image

Screening for Occult Heart Failure (HF) in Type 2 Diabetes Mellitus (T2DM) using NT-proBNP

Dr Ameya Joshi

Emily-Laus-interview-banner

Sex-specific Differences in Heart Failure

Prof Emily Lau

Headshots of Prof Alexandre Mebazaa and Asst Prof Jasper Tromp, next to a variety of pills, against a grey backdrop.

STRONG-HF: Enhancing GDMT regimen in Asia

<img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2023/03/Mebazaa-Cardio-ThinkLab-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://cardiothinklab.com/wp-content/uploads/2023/03/Mebazaa-Cardio-ThinkLab-150x150.png" width="150" height="150">

Prof Alexandre Mebazaa, Asst Prof Jasper Tromp, +1 more

DrMcGee

Heart Failure Care Beyond City Limits: Insights from a Cardiologist

Dr Michael McGee

Implementation of STRONG-HF protocol in heart failure management: an Australian perspective

Prof Andrew JS Coats

Human heart illustration. Text on the left reads: Strong-HF, Contemporary post-discharge management in heart-failure.

Unleashing the Power of STRONG-HF: Enabling Transformation in Heart Failure Management Across China

<img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" width="150" height="150">

Cardio ThinkLab

nhcs-article.-banner2

Reshaping HF Management at NHCS

<img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" width="150" height="150">

Cardio ThinkLab

Illustration of a blood clot in the coronary artery in front of a finger getting pricked by a lancet.

Screening & Diagnosis of Heart Failure in Pre-Diabetic and Diabetic Patients

<img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" width="150" height="150">

Cardio ThinkLab

Illustration of a human heart. Text on the left reads "World Heart Day, 29th September 2023."

Elevating CVD management in APAC to its Zenith- with Cardiac biomarkers

<img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" width="150" height="150">

Cardio ThinkLab

Dr Aekarach

Quantum leap in reducing rehospitalization in HF by 70-80% – How and where?

Dr Aekarach Ariyachaipanich

Prof Mebazaa, the principal investigator of STRONG-HF, giving a talk on his first-hand experience and insights on implementing the protocol.

STRONG-HF: Rapid Uptitration of Guideline Directed Medical Therapy for Heart Failure

<img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2023/03/Mebazaa-Cardio-ThinkLab-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://cardiothinklab.com/wp-content/uploads/2023/03/Mebazaa-Cardio-ThinkLab-150x150.png" width="150" height="150">

Prof Alexandre Mebazaa

Heart failure management in Australia and the role of NT-proBNP in monitoring and treatment

Prof John Amerena

Illustration of a doctor in a white coat, holding a briefcase and running down a white striped road. Text on the top reads: " Discover the APAC STRONG-HF master pack on Heart Failure Treatment Monitoring"

Download APAC STRONG-HF Master Pack: First-hand Insights from Prof Mebazaa on Heart Failure Treatment Monitoring

<img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" width="150" height="150">

Cardio ThinkLab

Heart Failure Management in India – Overcoming Present Challenges

Prof Upendra Kaul

Laptop showing an illustration of doctors standing around a heart, discussing diagnosis and treatment for heart failure, on a grey banner background. Text to the left read "STRONG-HF; contemporary post-discharge management in heart failure

STRONG-HF study highlighting benefits of treatment optimisation

<img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" width="150" height="150">

Cardio ThinkLab

STRONG-HF: Post-discharge Heart Failure Management and Implementation of GDMT Heart Failure Therapy

<img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2023/03/Mebazaa-Cardio-ThinkLab-150x150.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://cardiothinklab.com/wp-content/uploads/2023/03/Mebazaa-Cardio-ThinkLab-150x150.png" width="150" height="150">

Prof Alexandre Mebazaa

Dr-Andrew_banner

proCardio Asia Pacific

NT-proBNP and ECHO in heart failure – do they always go hand in hand?

<img src="https://cardiothinklab.com/wp-content/uploads/2022/03/Sindone-photo-150x150.png" width="150" height="150">

Prof Andrew Sindone

Dr-Jack-Tan_banner

proCardio Asia Pacific

APAC Heart Failure Gap Report

Dr Jack Tan

proCardio-David-Sim-new

proCardio Asia Pacific

Value of NT-ProBNP for Treatment Monitoring in CHF

<img src="https://cardiothinklab.com/wp-content/uploads/2021/07/david-sim-150x150.jpg" width="150" height="150">

Dr David Sim

Clinical Application Value of NT-proBNP in Chronic Kidney Diseases Patients with Cardiovascular Diseases

Dr Gan Liangying

Dr Francis Chow being interviewed

T2DM Patient Support Program in Hong Kong and the Value of NT-proBNP

Dr Francis CC Chow

NT-proBNP: Increasing Clinical Confidence in Heart Failure Management

<img src="https://cardiothinklab.com/wp-content/uploads/2022/03/Sindone-photo-150x150.png" width="150" height="150">

Prof Andrew Sindone

Dr-Sim-Clinical-Cases-Cardio-ThinkLab

Heart Failure in Asia – Present Challenges and Future Strategies

<img src="https://cardiothinklab.com/wp-content/uploads/2021/07/david-sim-150x150.jpg" width="150" height="150">

Dr David Sim

Heart Failure Prevention in T2DM – Essence of JCS/JDS joint consensus

Dr Yasunori Takata

Load more articles

2800+ Healthcare Professionals have cardiac insights delivered to their inbox

Sign up to receive the latest updates via your email